Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Allosteric Modulation: a Novel Approach To Drug Discovery

Allosteric modulators of GPCRs have emerged as a novel and highly desirable class of compounds, offering a number of distinct advantages over conventional competitive compounds; their increased selectivity, self-limiting activity and structural novelty should translate into promising new drugs for a wide range of diseases

Mark Epping-Jordan, Emmanuel Le Poul and Jean-Philippe Rocher (January 2008)

Keywords: Allosteric modulation, GPCRs as drugs, superior receptor subtype selectivity

    View full article    |    Back to Discovery Technology section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |